chronic heat b virus hb infect metres worldwide public health concern approx million people chronic infect risk develop liver cirrhosi hepatocellular carcinoma nucleotide analog num wide use therapy often require longlist administer avoid reactive withdraw therefore urgent need develop novel treatment shorten draw therapy accuser control complement effect avail antivirus virusspecif cell function defect exhaust state key determine persist reconstituted office cell response may thu metres ration strategy treat patient respect enhance adapt immune response checkpoint inhibitor blocked specify vaccine lymphocyte metal target autolog engine include chime antigen receptor car tcrredirect constitute promise modulators approach therapeutic restore protect immune advance emerge immunebas set research field outline 